Managed Care

Council Capital Enters Strategic Partnership With OccMD

Retrieved on: 
Monday, April 29, 2024
Other Health, Managed Care, General Health, Professional Services, Hospitals, Health Insurance, Insurance, Nursing, Human Resources, Practice Management, Health, Physical Therapy, Capital, Council Capital, Council, Veteran, Multimedia, Organization

Council Capital , a prominent healthcare-focused private equity firm, has partnered with OccMD, LLC , a physician-led medical and nurse case management company that gets better medical outcomes for injured workers at a fair cost for employers and other payers.

Key Points: 
  • Council Capital , a prominent healthcare-focused private equity firm, has partnered with OccMD, LLC , a physician-led medical and nurse case management company that gets better medical outcomes for injured workers at a fair cost for employers and other payers.
  • Based in Dallas, OccMD provides medical management services for organizations whose employees have complex work-related injuries or illnesses.
  • OccMD provides timely access to, and accountability from, highly qualified specialists, which helps to promote recovery.
  • “One of the reasons we decided to partner with Council Capital was to access the wealth of healthcare and workers’ comp industry knowledge and support found in its CEO Council,” Dr. Tonn said.

Study Finds Handheld Far UV-C Devices Effectively Reduce Surface Pathogens in a Healthcare Setting

Retrieved on: 
Monday, April 29, 2024
Technology, Health Technology, Research, Medical Devices, Infectious Diseases, Hospitals, Urban Planning, Clinical Trials, Public Transport, Transportation, Lodging, Health, Building Systems, Travel, Practice Management, Managed Care, General Health, Science, COVID-19, Transport, Other Technology, Other Construction & Property, Construction & Property, Other Health, Infection, The International, System, Partner, Filtration, Bone marrow, Safety, Bacteria, Disinfectant, University, Patient, Spore, Virus, Fungus, MD Anderson Cancer Center, Ultraviolet, Death, ICHS, Vaccine

In U.S. healthcare facilities alone, 1.7 million patients contract HAIs annually and HAIs cause 99,000 deaths every year .

Key Points: 
  • In U.S. healthcare facilities alone, 1.7 million patients contract HAIs annually and HAIs cause 99,000 deaths every year .
  • Surface pathogens can persist for days to months and studies show that 50% of surfaces in healthcare environments do not receive adequate levels of disinfection during manual chemical cleaning.
  • This study continued to validate the highly effective and rapid reduction of harmful pathogens on most high touch surfaces.
  • “This study provides further real-world data on the efficacy of handheld Filtered Far UV-C devices to reduce surface pathogens which we hope could ultimately improve patient care and tackle the tremendous expenses healthcare institutions face in fighting HAIs,” said Jennifer Rosen, co-founder of Freestyle Partners, LLC.

PointClickCare Enhances the Senior Living Experience with New Purpose-Built Solutions

Retrieved on: 
Monday, April 29, 2024
Data Management, Technology, Managed Care, Other Health, Health, General Health, Seniors, Health Technology, Software, Artificial Intelligence, Consumer, Argentum, Food safety, Emerging market, Silver, Conference, Life, Senior, Pharmacy, Senior living, Management

From April 29 – May 1, the company will be exhibiting its latest solutions including Pharmacy Connect , PointClickCare Connect for Senior Living, and Mealtime Solutions, a brand-new all-in-one foodservice management technology, powered by MealSuite.

Key Points: 
  • From April 29 – May 1, the company will be exhibiting its latest solutions including Pharmacy Connect , PointClickCare Connect for Senior Living, and Mealtime Solutions, a brand-new all-in-one foodservice management technology, powered by MealSuite.
  • As part of its effort to further empower senior living providers to become the community of choice for residents and staff alike, PointClickCare will showcase these new innovations, which have been specifically designed to meet the unique needs of senior living communities.
  • Argentum Senior Living Executive Conference brings together thousands of senior living professionals, operators, owners, executives, and community leaders for an elevated educational experience that recognizes the unique challenges facing senior living professionals today.
  • To learn more about how PointClickCare’s purpose-built solutions can help to enable greater success and collaboration for senior living communities, click here .

Lower Lights Health and AndHealth Achieve Pharmacy Accreditation With ACHC

Retrieved on: 
Friday, April 26, 2024
Health, Hospitals, Health Technology, Other Health, Managed Care, General Health, Pharmaceutical, Cloud, ACHC, Patient, CMS, ISO 9001:2015, Partnership, Prescription, Accreditation, Hospice, Hospital

Lower Lights Health and AndHealth proudly announce they have achieved accreditation through Accreditation Commission for Health Care (ACHC) for Lower Lights Pharmacy’s specialty pharmacy services.

Key Points: 
  • Lower Lights Health and AndHealth proudly announce they have achieved accreditation through Accreditation Commission for Health Care (ACHC) for Lower Lights Pharmacy’s specialty pharmacy services.
  • Accreditation by ACHC reflects an organization’s dedication and commitment to meeting standards that facilitate a higher level of performance and patient care.
  • Through a partnership with AndHealth, Lower Lights Health now offers specialty pharmacy services in-house and patients can fill their specialty prescriptions directly through Lower Lights Health Pharmacy.
  • We are honored to have received ACHC accreditation, which is a great testament to the attention to detail and care our patients can expect from our pharmacy team,” said Tracy Cloud, CEO of Lower Lights Health.

CareTrust REIT Sets First Quarter Earnings Call for Friday, May 3, 2024

Retrieved on: 
Friday, April 26, 2024
Commercial Building & Real Estate, Seniors, Construction & Property, Managed Care, Health, REIT, Consumer, Residential Building & Real Estate, Webcast, ID, Security (finance)

CareTrust REIT, Inc. (NYSE:CTRE) announced today that it plans to release its first quarter 2024 financial results after the U.S. markets close on Thursday, May 2, 2024.

Key Points: 
  • CareTrust REIT, Inc. (NYSE:CTRE) announced today that it plans to release its first quarter 2024 financial results after the U.S. markets close on Thursday, May 2, 2024.
  • Representatives of CareTrust REIT’s management team will host a conference call to discuss the results and other current matters the following day.
  • CareTrust REIT invites current and prospective investors to listen to the call on Friday, May 3, 2024 at 1:00 p.m. Eastern Time (10:00 a.m. Pacific Time).
  • A recording of the call will be available for replay via the website for approximately 30 days following the call.

Vagus nerve activation of the spleen shows promise to treat infections, Feinstein Institutes research

Retrieved on: 
Friday, April 26, 2024
Biotechnology, Managed Care, Health, General Health, Pharmaceutical, Health Technology, Other Science, Research, Hospitals, Science, Clinical Trials, Diamond, Autoantibody, Cancer, Bangladesh Technical Education Board, Inflammation, Biomedical engineering, National academy, National Academy of Sciences, Mouse, Crohn's disease, Pulmonary hypertension, Map, Science Advances, Vagus nerve stimulation, Inflammatory Bowel Diseases, Diabetes, Interface (computing), Neuroscience, Acetylcholine, Doctor of Philosophy, Spleen, VNS, DRS, Disease, Anatomy, Human, Sensation, Autoimmune disease, Nervous system, Arthritis, Molecular medicine, Physiology, Medicine, Immunology, Medical research, Multimedia, Lupus, Immune system, Antibody, Paralysis, Immunity, Credit, Autoimmunity, Sepsis, Vagus nerve, Vaccine

New research published in Science Advances by The Feinstein Institutes for Medical Research scientists shows that activation of the vagus nerve triggers the spleen, thereby regulating the production of antibodies.

Key Points: 
  • New research published in Science Advances by The Feinstein Institutes for Medical Research scientists shows that activation of the vagus nerve triggers the spleen, thereby regulating the production of antibodies.
  • This research highlights how the nervous system regulates immunity and suggests potential for non-pharmalogical, vagus nerve modulation to treat a variety of diseases, like lupus and sepsis.
  • Dr. Zanos’s research focus is on understanding the anatomy and physiology of the vagus nerve and the effects vagus nerve stimulation has in inflammation and cardiovascular diseases.
  • At the Feinstein Institutes, medical researchers use modern technology to develop new device-based therapies to treat disease and injury.

Latin America CDC a Must, say Public Health Leaders and AHF

Retrieved on: 
Friday, April 26, 2024
COVID-19, Infectious Diseases, Hospitals, Hispanic, Other Health, Managed Care, Health, Consumer, General Health, Mark R. Dybul, Public, University, Pandemic, AIDS, Safety, Public health, World Health Organization, Policy, CDC, Dengue fever, AH1N1, Infection, LATAM, Research, Vaccine, Cayetano Heredia University, Emergency, AIDS Healthcare Foundation, Acquisition, Data collection, Private sector, Death, Faculty, AHF, Lancet

This new agency would seek to strengthen regional resilience against future health crises through collaboration and resource optimization among nations.

Key Points: 
  • This new agency would seek to strengthen regional resilience against future health crises through collaboration and resource optimization among nations.
  • Patricia J. Garcia, former health minister of Peru, principal professor of the Faculty of Public Health of the Universidad Peruana Cayetano Heredia, and one of the initiative's proponents, emphasized the importance of this regional collaboration: "The experience with COVID-19 demonstrated critical deficiencies in our public health infrastructure.
  • The LATAM CDC will serve as a fundamental pillar for prevention, preparedness, and rapid response to future health emergencies, thus strengthening our regional health sovereignty."
  • To learn more about the AHF Global Public Health Institute, visit https://ahfinstitute.org/ .

4P-Pharma Announces Total Capital of €15 Million Successfully Secured in Second Closing

Retrieved on: 
Monday, April 29, 2024
Research, Managed Care, Professional Services, Pharmaceutical, Fitness & Nutrition, Clinical Trials, Science, Biotechnology, Finance, Other Science, Health, Diabetes, Multimedia, Patient, Growth, MOA, Pharma, Pharmaceutical industry

4P-Pharma, a Lille-based clinical-stage startup studio focused on developing curative therapies for untreated serious diseases, announces that it has successfully secured a total capital of €15 million in its second closing with participation from private investors.

Key Points: 
  • 4P-Pharma, a Lille-based clinical-stage startup studio focused on developing curative therapies for untreated serious diseases, announces that it has successfully secured a total capital of €15 million in its second closing with participation from private investors.
  • View the full release here: https://www.businesswire.com/news/home/20240424933193/en/
    With this funding, 4P-Pharma's shareholders renew their confidence in the company's drug regeneration model for untreated serious diseases.
  • They welcome the entry of Phase 2 clinical development of the two first 4P-Pharma's SPVs, underlying the robust potential of the company's business model.
  • It attests to the strength of our model for delivering first-in-class treatments for people suffering from untreated serious diseases."

C2N Diagnostics Expands Into Japan Through Mediford Corporation Partnership With Precivity™ Blood Testing for Alzheimer’s Disease and Brain Research Market

Retrieved on: 
Friday, April 26, 2024
Research, Managed Care, Pharmaceutical, Consumer, Mental Health, Health Technology, Clinical Trials, Science, Biotechnology, Neurology, Seniors, Health, Epidemiology, Biogen, Brain, Protein, Learning, Donanemab, Clarity, Prognosis, Partnership, PET, Pathology, Non-fungible token, Dementia, Alzheimer's disease, Hoshiko Yamane, DSM-IV codes, Peptide, Diagnosis, Biomarker, Ageing, Clinical trial, Medical imaging

Hoshiko, who’s based in Kyoto, Japan, has a well-established background as a neuroscientist focused on the commercialization aspects of the field.

Key Points: 
  • Hoshiko, who’s based in Kyoto, Japan, has a well-established background as a neuroscientist focused on the commercialization aspects of the field.
  • Other research has found that Japan has the highest proportion of people with dementia of any country.
  • We believe our partnership with Mediford Corporation will unlock many opportunities and possibilities.
  • Mediford Corporation is known for providing clinical and non-clinical analysis that supports each stage of drug research and development, including advanced treatment options.

Edwards Lifesciences Reports First Quarter Results

Retrieved on: 
Thursday, April 25, 2024
Managed Care, Biotechnology, Health, Cardiology, Acumen, Mortality, FDA, Critical care, Investment, Pulmonary artery catheter, Research, Trial of the century, Aortic stenosis, Growth, Ultra, U.S. FDA, ICU, TAVR, Patient, PROGRESS, EPS, Hospital, PASCAL, Quality of life, M3, Heart failure, Pharmaceutical industry

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended March 31, 2024.

Key Points: 
  • Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended March 31, 2024.
  • Surgical Structural Heart sales for the quarter were $266 million, which grew 7%, or 8% on a constant currency basis.
  • For the quarter, the adjusted gross profit margin was 76.0%, compared to 77.5% in the same period last year.
  • For the second quarter of 2024, the company projects total sales to be between $1.62 and $1.70 billion, and adjusted EPS of $0.67 to $0.71.